Monoclonal antibody-based sensitive enzyme-linked immunosorbent assay for murine serum amyloid A

Journal of Immunoassay

Volumn 20, Issue 4, 1999, Pages 223-235

  Yamada, Toshiyuki ^a   Fukuda, Takeaki ^b   Wada, Atsufumi ^a   Itoh, Yoshihisa ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Inflammation; Monoclonal antibody; Mouse; Serum amyloid A

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL;

EID: 0032694091     PISSN: 01971522     EISSN: None     Source Type: Journal    
DOI: 10.1080/01971529909349352     Document Type: Article

References (14)

1. Baumann, H. and Gauldie, J. The acute phase response. Immunol. Today 1994; 15: 74-80.
2. Steel, D.M. and Whitehead, A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 1994; 15:81-8.
3. Husby, G., Marhaug, G., Dowton, B., Sletten, K., and Sipe, J.D. Serum amyloid A (SAA):biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid Int. J. Exp. Clin. Invest. 1994; 1:119-37.
4. Pepys, M.B., Booth, D.R., Hutchinson, W.L., Gallimore, J.R., Collins, P.M., and Hohenester, E. Amyloid P component. A critical review. Amyloid Int. J. Exp. Clin. Invest. 1997; 4: 274-95.
5. Wood, D.D., Gammon, M., and Staruch, M.J. An ELISA assay for murine amyloid A and serum amyloid A utilizing monoclonal antibodies. J. Immunol. Methods 1982; 55: 19-26.
6. Zuckerman, S.H., and Surprenant, Y.M. Simplified microELISA for the quantitation of murine serum amyloid A protein. J. Immunol. Methods 1986; 92: 37-43.
7. Yamada, T., Hirano, N., Kuroda, T., Okuda, Y., and Itoh, Y. Generation and characterization of rat monoclonal antibodies against human serum amyloid A. Scand. J. Immunol. 1997; 46:175-9.
8. Sipe, J.D. Revised nomenclature for serum amyloid A (SAA). Amyloid Int. J. Exp. Clin. Invest. 1999, in press.
9. Kluve-Beckerman, B., Yamada, T., Hardwick, J., Liepnieks, J.J., and Benson M.D. Differential plasma clearance of murine acute-phase amyloid A proteins SAA1 and SAA2. Biochem. J . 1997; 322: 663-9.
10. Yamada, T., Liepnieks, J.J., Benson, M.D., and Kluve-Beckerman, B. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin. J. Immunol. 1996; 157: 901-7.
11. Pras, M., Schubert, M., Zucker-Franklin, D., Rimon, A., and Franklin, E. The characterization of soluble amyloid prepared in water. J . Clin. Invest. 1968; 47: 924-33.
12. Yamada, T., Kluve-Beckerman, B., Kuster, W.M., Liepnieks, J.J., and Benson, M.D. Measurement of serum amyloid A4 (SAA4) :its constitutive presence in serum. Amyloid Int. J. Exp. Clin. Invest. 1994; 1:114-8.
13. Godenir, N.L., Jeenah, M.S., Coetzee, G.A., van der Westhuyzen, D.R., Strachan A.G., and de Beer, F.C. Standardization of the quantitation of serum amyloid A protein (SAA) in human serum. J. Immunol. Methods 1985; 83: 217-25.
14. Sipe, J.D., Gonnerman, W.A., Loose, L.D., Knapschaefer, G., Xie, W.J., and Franzblau, C. Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J. Immunol. Methods 1989; 125: 125-35.